nogrЭкспериментальная и клиническая гастроэнтерологияExperimental and Clinical Gastroenterology1682-8658«Global Media Technologies»10.31146/1682-8658-ecg-222-2-111-119nogr-2587Research ArticleОБЗОРREVIEWМальнутриция, нарушение функции желудочно-кишечного тракта и саркопения - особенности сочетанной патологииMalnutrition, dysfunction of the gastrointestinal tract and sarcopenia - features of combined pathologyhttps://orcid.org/0000-0003-4114-5233КурмаевД. П.KurmaevD. P.geriatry@mail.ruhttps://orcid.org/0000-0003-0027-1786БулгаковаС. В.BulgakovaS. V.noemail@neicon.ruhttps://orcid.org/0000-0003-0097-7252ТреневаЕ. В.TrenevaE. V.noemail@neicon.ruhttps://orcid.org/0000-0002-9609-2725ПервышинН. А.PervyshinN. A.noemail@neicon.ruhttps://orcid.org/0000-0001-8827-4919ШароноваЛ. А.SharonovaL. A.noemail@neicon.ruhttps://orcid.org/0000-0001-6678-6411ДолгихЮ. А.DolgikhYu. A.noemail@neicon.ruФедеральное государственное бюджетное образовательное учреждение высшего образования «Самарский государственный медицинский университет» Министерства здравоохранения Российской ФедерацииРоссияSamara State Medical University of the Ministry of Healthcare of the Russian FederationRussian Federation20242603202402111119Copyright © Курмаев Д.П., Булгакова С.В., Тренева Е.В., Первышин Н.А., Шаронова Л.А., Долгих Ю.А., 20242024Курмаев Д.П., Булгакова С.В., Тренева Е.В., Первышин Н.А., Шаронова Л.А., Долгих Ю.А.Kurmaev D.P., Bulgakova S.V., Treneva E.V., Pervyshin N.A., Sharonova L.A., Dolgikh Y.A.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.nogr.org/jour/article/view/2587

Одним из факторов риска развития саркопении является мальнутриция. Ухудшение энергетической ценности пищевого рациона, сбалансированности белков, жиров и углеводов, снижение белково-аминокислотного компонента питательного рациона - всё это может привести к развитию саркопении. Важную роль в процессе роста и развития мышечной ткани, в предотвращении ее деградации с возрастом играет микрофлора кишечника. Жировой гепатоз и цирроз печени также могут служить причиной развития саркопении. Проблема является актуальной и современной, и нуждается в изучении, чему и посвящен данный обзор литературы.

One of the risk factors for the development of sarcopenia is malnutrition. Impairment of the energy value of the diet, the balance of proteins, fats and carbohydrates, a decrease in the protein-amino acid component of the nutritional diet - all this can lead to the development of sarcopenia. The intestinal microflora plays an important role in the process of growth and development of muscle tissue, in preventing its degradation with age. Fatty hepatosis and cirrhosis of the liver can also cause the development of sarcopenia. The problem is urgent and modern, and needs to be studied, which is what this literature review is dedicated to.

саркопениястарческая астениякахексиястарениепищеварениежелудочно-кишечный трактмальабсорбциямальнутрицияцирроз печениsarcopeniafrailtycachexiaagingdigestiongastrointestinal tractmalabsorptionmalnutritionliver cirrhosisReferencesCruz-Jentoft A. J., Bahat G., Bauer J. et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(4):601. doi: 10.1093/ageing/afz046.Cruz-Jentoft A. J., Bahat G., Bauer J. et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(4):601. doi: 10.1093/ageing/afz046.Beaudart C., Rizzoli R., Bruyère O. et al. Sarcopenia: burden and challenges for public health. Arch Public Health. 2014;72(1):45. doi: 10.1186/2049-3258-72-45.Beaudart C., Rizzoli R., Bruyère O. et al. Sarcopenia: burden and challenges for public health. Arch Public Health. 2014;72(1):45. doi: 10.1186/2049-3258-72-45.von Haehling S., Morley J. E., Anker S. D. An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle. 2010;1(2):129-133. doi: 10.1007/s13539-010-0014-2.von Haehling S., Morley J. E., Anker S. D. An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle. 2010;1(2):129-133. doi: 10.1007/s13539-010-0014-2.Waters D. L., Baumgartner R. N., Garry P. J., Vellas B. Advantages of dietary, exercise-related, and therapeutic interventions to prevent and treat sarcopenia in adult patients: an update. Clin Interv Aging. 2010;5:259-270. doi: 10.2147/cia.s6920.Waters D. L., Baumgartner R. N., Garry P. J., Vellas B. Advantages of dietary, exercise-related, and therapeutic interventions to prevent and treat sarcopenia in adult patients: an update. Clin Interv Aging. 2010;5:259-270. doi: 10.2147/cia.s6920.Chen L. K., Woo J., Assantachai P. et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020;21(3):300-307.e2. doi: 10.1016/j.jamda.2019.12.012.Chen L. K., Woo J., Assantachai P. et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020;21(3):300-307.e2. doi: 10.1016/j.jamda.2019.12.012.Liu C., Cheung W. H., Li J. et al. Understanding the gut microbiota and sarcopenia: a systematic review. J Cachexia Sarcopenia Muscle. 2021;12(6):1393-1407. doi: 10.1002/jcsm.12784.Liu C., Cheung W. H., Li J. et al. Understanding the gut microbiota and sarcopenia: a systematic review. J Cachexia Sarcopenia Muscle. 2021;12(6):1393-1407. doi: 10.1002/jcsm.12784.Cruz-Jentoft A. J., Landi F., Schneider S. M. et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014;43(6):748-759. doi: 10.1093/ageing/afu115.Cruz-Jentoft A. J., Landi F., Schneider S. M. et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014;43(6):748-759. doi: 10.1093/ageing/afu115.Kwak J. Y., Kwon K. S. Pharmacological Interventions for Treatment of Sarcopenia: Current Status of Drug Development for Sarcopenia. Ann Geriatr Med Res. 2019;23(3):98-104. doi: 10.4235/agmr.19.0028.Kwak J. Y., Kwon K. S. Pharmacological Interventions for Treatment of Sarcopenia: Current Status of Drug Development for Sarcopenia. Ann Geriatr Med Res. 2019;23(3):98-104. doi: 10.4235/agmr.19.0028.Hawley-Hague H., Horne M., Campbell M. et al. Multiple levels of influence on older adults’ attendance and adherence to community exercise classes. Gerontologist. 2014;54(4):599-610. doi: 10.1093/geront/gnt075.Hawley-Hague H., Horne M., Campbell M. et al. Multiple levels of influence on older adults’ attendance and adherence to community exercise classes. Gerontologist. 2014;54(4):599-610. doi: 10.1093/geront/gnt075.Milanović Z., Pantelić S., Trajković N. et al. Age-related decrease in physical activity and functional fitness among elderly men and women. Clin Interv Aging. 2013;8:549-556. doi: 10.2147/CIA.S44112.Milanović Z., Pantelić S., Trajković N. et al. Age-related decrease in physical activity and functional fitness among elderly men and women. Clin Interv Aging. 2013;8:549-556. doi: 10.2147/CIA.S44112.Kamei Y., Hatazawa Y., Uchitomi R. et al. Regulation of Skeletal Muscle Function by Amino Acids. Nutrients. 2020;12(1):261. doi: 10.3390/nu12010261.Kamei Y., Hatazawa Y., Uchitomi R. et al. Regulation of Skeletal Muscle Function by Amino Acids. Nutrients. 2020;12(1):261. doi: 10.3390/nu12010261.Robinson S. M., Reginster J. Y., Rizzoli R. et al. Does nutrition play a role in the prevention and management of sarcopenia? Clin Nutr. 2018;37(4):1121-1132. doi: 10.1016/j.clnu.2017.08.016.Robinson S. M., Reginster J. Y., Rizzoli R. et al. Does nutrition play a role in the prevention and management of sarcopenia? Clin Nutr. 2018;37(4):1121-1132. doi: 10.1016/j.clnu.2017.08.016.Yoshimura Y., Wakabayashi H., Yamada M. et al.Interventions for Treating Sarcopenia: A Systematic Review and Meta-Analysis of Randomized Controlled Studies. J Am Med Dir Assoc. 2017;18(6):553.e1-553.e16. doi: 10.1016/j.jamda.2017.03.019.Yoshimura Y., Wakabayashi H., Yamada M. et al.Interventions for Treating Sarcopenia: A Systematic Review and Meta-Analysis of Randomized Controlled Studies. J Am Med Dir Assoc. 2017;18(6):553.e1-553.e16. doi: 10.1016/j.jamda.2017.03.019.Park J., Levic D. S., Sumigray K. D. et al. Lysosome-Rich Enterocytes Mediate Protein Absorption in the Vertebrate Gut. Dev Cell. 2019;51(1):7-20.e6. doi: 10.1016/j.devcel.2019.08.001Park J., Levic D. S., Sumigray K. D. et al. Lysosome-Rich Enterocytes Mediate Protein Absorption in the Vertebrate Gut. Dev Cell. 2019;51(1):7-20.e6. doi: 10.1016/j.devcel.2019.08.001Zavyalova A. N., Novikova V. P., Ignatova P. D. Axis “microbiota - muscle”. Experimental and Clinical Gastroenterology. 2022;207(11): 60-69. (In Russ.) doi: 10.31146/1682-8658-ecg-207-11-60-69.@@ Завьялова А. Н., Новикова В. П., Игнатова П. Д. Ось «микробиота - мышцы». Экспериментальная и клиническая гастроэнтерология. 2022;207(11): 60-69. doi: 10.31146/1682-8658-ecg-207-11-60-69.Zavyalova A. N., Novikova V. P., Ignatova P. D. Axis “microbiota - muscle”. Experimental and Clinical Gastroenterology. 2022;207(11): 60-69. (In Russ.) doi: 10.31146/1682-8658-ecg-207-11-60-69.@@ Завьялова А. Н., Новикова В. П., Игнатова П. Д. Ось «микробиота - мышцы». Экспериментальная и клиническая гастроэнтерология. 2022;207(11): 60-69. doi: 10.31146/1682-8658-ecg-207-11-60-69.Lee P. C., Lee K. C., Yang T. C. et al. Sarcopenia-related gut microbial changes are associated with the risk of complications in people with cirrhosis. JHEP Rep. 2022;5(1):100619. doi: 10.1016/j.jhepr.2022.100619.Lee P. C., Lee K. C., Yang T. C. et al. Sarcopenia-related gut microbial changes are associated with the risk of complications in people with cirrhosis. JHEP Rep. 2022;5(1):100619. doi: 10.1016/j.jhepr.2022.100619.Zhai J., Ma B., Qin J. et al. Alcohol consumption patterns and the risk of sarcopenia: a population-based cross-sectional study among chinese women and men from Henan province. BMC Public Health. 2022;22(1):1894. doi: 10.1186/s12889-022-14275-6.Zhai J., Ma B., Qin J. et al. Alcohol consumption patterns and the risk of sarcopenia: a population-based cross-sectional study among chinese women and men from Henan province. BMC Public Health. 2022;22(1):1894. doi: 10.1186/s12889-022-14275-6.Steiner J. L., Kimball S. R., Lang C. H. Acute Alcohol-Induced Decrease in Muscle Protein Synthesis in Female Mice Is REDD-1 and mTOR-Independent. Alcohol Alcohol. 2016;51(3):242-250. doi: 10.1093/alcalc/agv105.Steiner J. L., Kimball S. R., Lang C. H. Acute Alcohol-Induced Decrease in Muscle Protein Synthesis in Female Mice Is REDD-1 and mTOR-Independent. Alcohol Alcohol. 2016;51(3):242-250. doi: 10.1093/alcalc/agv105.Lang C. H., Pruznak A. M., Nystrom G. J., Vary T. C. Alcohol-induced decrease in muscle protein synthesis associated with increased binding of mTOR and raptor: Comparable effects in young and mature rats. Nutr Metab (Lond). 2009;6:4. doi: 10.1186/1743-7075-6-4.Lang C. H., Pruznak A. M., Nystrom G. J., Vary T. C. Alcohol-induced decrease in muscle protein synthesis associated with increased binding of mTOR and raptor: Comparable effects in young and mature rats. Nutr Metab (Lond). 2009;6:4. doi: 10.1186/1743-7075-6-4.Hyun J., Han J., Lee C. et al. Pathophysiological Aspects of Alcohol Metabolism in the Liver.Int J Mol Sci. 2021;22(11):5717. doi: 10.3390/ijms22115717.Hyun J., Han J., Lee C. et al. Pathophysiological Aspects of Alcohol Metabolism in the Liver.Int J Mol Sci. 2021;22(11):5717. doi: 10.3390/ijms22115717.Devaraj S., Hemarajata P., Versalovic J. The human gut microbiome and body metabolism: implications for obesity and diabetes. Clin Chem. 2013;59(4):617-628. doi: 10.1373/clinchem.2012.187617.Devaraj S., Hemarajata P., Versalovic J. The human gut microbiome and body metabolism: implications for obesity and diabetes. Clin Chem. 2013;59(4):617-628. doi: 10.1373/clinchem.2012.187617.Sonnenburg E. D., Zheng H., Joglekar P. et al. Specificity of polysaccharide use in intestinal bacteroides species determines diet-induced microbiota alterations. Cell. 2010;141(7):1241-1252. doi: 10.1016/j.cell.2010.05.005.Sonnenburg E. D., Zheng H., Joglekar P. et al. Specificity of polysaccharide use in intestinal bacteroides species determines diet-induced microbiota alterations. Cell. 2010;141(7):1241-1252. doi: 10.1016/j.cell.2010.05.005.Faith J. J., McNulty N. P., Rey F. E., Gordon J. I. Predicting a human gut microbiota’s response to diet in gnotobiotic mice. Science. 2011;333(6038):101-104. doi: 10.1126/science.1206025.Faith J. J., McNulty N. P., Rey F. E., Gordon J. I. Predicting a human gut microbiota’s response to diet in gnotobiotic mice. Science. 2011;333(6038):101-104. doi: 10.1126/science.1206025.Shreiner A. B., Kao J. Y., Young V. B. The gut microbiome in health and in disease. Curr Opin Gastroenterol. 2015;31(1):69-75. doi: 10.1097/MOG.0000000000000139.Shreiner A. B., Kao J. Y., Young V. B. The gut microbiome in health and in disease. Curr Opin Gastroenterol. 2015;31(1):69-75. doi: 10.1097/MOG.0000000000000139.Nicholson J. K., Holmes E., Kinross J. et al. Host-gut microbiota metabolic interactions. Science. 2012;336(6086):1262-1267. doi: 10.1126/science.1223813.Nicholson J. K., Holmes E., Kinross J. et al. Host-gut microbiota metabolic interactions. Science. 2012;336(6086):1262-1267. doi: 10.1126/science.1223813.Kalliomäki M., Collado M. C., Salminen S., Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr. 2008;87(3):534-538. doi: 10.1093/ajcn/87.3.534.Kalliomäki M., Collado M. C., Salminen S., Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr. 2008;87(3):534-538. doi: 10.1093/ajcn/87.3.534.Gizard F., Fernandez A., De Vadder F.Interactions between gut microbiota and skeletal muscle. Nutr Metab Insights. 2020;13:1178638820980490. doi: 10.1177/1178638820980490.Gizard F., Fernandez A., De Vadder F.Interactions between gut microbiota and skeletal muscle. Nutr Metab Insights. 2020;13:1178638820980490. doi: 10.1177/1178638820980490.Dethlefsen L., Relman D. A. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A. 2011;108 Suppl 1(Suppl 1):4554-4561. doi: 10.1073/pnas.1000087107.Dethlefsen L., Relman D. A. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A. 2011;108 Suppl 1(Suppl 1):4554-4561. doi: 10.1073/pnas.1000087107.Kallus S. J., Brandt L. J. The intestinal microbiota and obesity. J Clin Gastroenterol. 2012;46(1):16-24. doi: 10.1097/MCG.0b013e31823711fd.Kallus S. J., Brandt L. J. The intestinal microbiota and obesity. J Clin Gastroenterol. 2012;46(1):16-24. doi: 10.1097/MCG.0b013e31823711fd.Jiang H., Chen C., Gao J. Extensive Summary of the Important Roles of Indole Propionic Acid, a Gut Microbial Metabolite in Host Health and Disease. Nutrients. 2022;15(1):151. doi: 10.3390/nu15010151.Jiang H., Chen C., Gao J. Extensive Summary of the Important Roles of Indole Propionic Acid, a Gut Microbial Metabolite in Host Health and Disease. Nutrients. 2022;15(1):151. doi: 10.3390/nu15010151.Das B., Nair G. B. Homeostasis and dysbiosis of the gut microbiome in health and disease. J Biosci. 2019;44(5):117.Das B., Nair G. B. Homeostasis and dysbiosis of the gut microbiome in health and disease. J Biosci. 2019;44(5):117.Richards J. L., Yap Y. A., McLeod K. H. et al. Dietary metabolites and the gut microbiota: an alternative approach to control inflammatory and autoimmune diseases. Clin Transl Immunology. 2016;5(5): e82. doi: 10.1038/cti.2016.29.Richards J. L., Yap Y. A., McLeod K. H. et al. Dietary metabolites and the gut microbiota: an alternative approach to control inflammatory and autoimmune diseases. Clin Transl Immunology. 2016;5(5): e82. doi: 10.1038/cti.2016.29.Agus A., Planchais J., Sokol H. Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. Cell Host Microbe. 2018;23(6):716-724. doi: 10.1016/j.chom.2018.05.003.Agus A., Planchais J., Sokol H. Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. Cell Host Microbe. 2018;23(6):716-724. doi: 10.1016/j.chom.2018.05.003.Gao K., Mu C. L., Farzi A., Zhu W. Y. Tryptophan Metabolism: A Link Between the Gut Microbiota and Brain. Adv Nutr. 2020;11(3):709-723. doi: 10.1093/advances/nmz127.Gao K., Mu C. L., Farzi A., Zhu W. Y. Tryptophan Metabolism: A Link Between the Gut Microbiota and Brain. Adv Nutr. 2020;11(3):709-723. doi: 10.1093/advances/nmz127.Alkhalaf L. M., Ryan K. S. Biosynthetic manipulation of tryptophan in bacteria: pathways and mechanisms. Chem Biol. 2015;22(3):317-328. doi: 10.1016/j.chembiol.2015.02.005Alkhalaf L. M., Ryan K. S. Biosynthetic manipulation of tryptophan in bacteria: pathways and mechanisms. Chem Biol. 2015;22(3):317-328. doi: 10.1016/j.chembiol.2015.02.005Thomas C. M., Hong T., van Pijkeren J. P. et al. Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling. PLoS One. 2012;7(2): e31951. doi: 10.1371/journal.pone.0031951.Thomas C. M., Hong T., van Pijkeren J. P. et al. Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling. PLoS One. 2012;7(2): e31951. doi: 10.1371/journal.pone.0031951.Kim J. Y., Chung E. J., Kim J. H. et al. Response to steroid treatment in anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia, stiff person syndrome and polyendocrinopathy. Mov Disord. 2006;21(12):2263-2264. doi: 10.1002/mds.21041.Kim J. Y., Chung E. J., Kim J. H. et al. Response to steroid treatment in anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia, stiff person syndrome and polyendocrinopathy. Mov Disord. 2006;21(12):2263-2264. doi: 10.1002/mds.21041.Huey S. L., Jiang L., Fedarko M. W. et al. Nutrition and the Gut Microbiota in 10- to 18-Month-Old Children Living in Urban Slums of Mumbai, India. mSphere. 2020;5(5): e00731-20. doi: 10.1128/mSphere.00731-20.Huey S. L., Jiang L., Fedarko M. W. et al. Nutrition and the Gut Microbiota in 10- to 18-Month-Old Children Living in Urban Slums of Mumbai, India. mSphere. 2020;5(5): e00731-20. doi: 10.1128/mSphere.00731-20.Ticinesi A., Lauretani F., Milani C. et al. Aging Gut Microbiota at the Cross-Road between Nutrition, Physical Frailty, and Sarcopenia: Is There a Gut-Muscle Axis?. Nutrients. 2017;9(12):1303. doi: 10.3390/nu9121303.Ticinesi A., Lauretani F., Milani C. et al. Aging Gut Microbiota at the Cross-Road between Nutrition, Physical Frailty, and Sarcopenia: Is There a Gut-Muscle Axis?. Nutrients. 2017;9(12):1303. doi: 10.3390/nu9121303.Berg G., Rybakova D., Fischer D. et al. Microbiome definition re-visited: old concepts and new challenges. Microbiome. 2020;8(1):103. doi: 10.1186/s40168-020-00875-0.Berg G., Rybakova D., Fischer D. et al. Microbiome definition re-visited: old concepts and new challenges. Microbiome. 2020;8(1):103. doi: 10.1186/s40168-020-00875-0.Daily J. W., Park S. Sarcopenia Is a Cause and Consequence of Metabolic Dysregulation in Aging Humans: Effects of Gut Dysbiosis, Glucose Dysregulation, Diet and Lifestyle. Cells. 2022;11(3):338. doi: 10.3390/cells11030338.Daily J. W., Park S. Sarcopenia Is a Cause and Consequence of Metabolic Dysregulation in Aging Humans: Effects of Gut Dysbiosis, Glucose Dysregulation, Diet and Lifestyle. Cells. 2022;11(3):338. doi: 10.3390/cells11030338.Grosicki G. J., Fielding R. A., Lustgarten M. S. Gut Microbiota Contribute to Age-Related Changes in Skeletal Muscle Size, Composition, and Function: Biological Basis for a Gut-Muscle Axis. Calcif Tissue Int. 2018;102(4):433-442. doi: 10.1007/s00223-017-0345-5.Grosicki G. J., Fielding R. A., Lustgarten M. S. Gut Microbiota Contribute to Age-Related Changes in Skeletal Muscle Size, Composition, and Function: Biological Basis for a Gut-Muscle Axis. Calcif Tissue Int. 2018;102(4):433-442. doi: 10.1007/s00223-017-0345-5.Ragonnaud E., Biragyn A. Gut microbiota as the key controllers of “healthy” aging of elderly people. Immun Ageing. 2021;18(1):2. doi: 10.1186/s12979-020-00213-w.Ragonnaud E., Biragyn A. Gut microbiota as the key controllers of “healthy” aging of elderly people. Immun Ageing. 2021;18(1):2. doi: 10.1186/s12979-020-00213-w.Clarke S. F., Murphy E. F., O’Sullivan O. et al. Exercise and associated dietary extremes impact on gut microbial diversity. Gut. 2014;63(12):1913-1920. doi: 10.1136/gutjnl-2013-306541.Clarke S. F., Murphy E. F., O’Sullivan O. et al. Exercise and associated dietary extremes impact on gut microbial diversity. Gut. 2014;63(12):1913-1920. doi: 10.1136/gutjnl-2013-306541.Schroeder B. O., Bäckhed F. Signals from the gut microbiota to distant organs in physiology and disease. Nat Med. 2016;22(10):1079-1089. doi: 10.1038/nm.4185.Schroeder B. O., Bäckhed F. Signals from the gut microbiota to distant organs in physiology and disease. Nat Med. 2016;22(10):1079-1089. doi: 10.1038/nm.4185.Fielding R. A., Reeves A. R., Jasuja R. et al. Muscle strength is increased in mice that are colonized with microbiota from high-functioning older adults. Exp Gerontol. 2019;127:110722. doi: 10.1016/j.exger.2019.110722.Fielding R. A., Reeves A. R., Jasuja R. et al. Muscle strength is increased in mice that are colonized with microbiota from high-functioning older adults. Exp Gerontol. 2019;127:110722. doi: 10.1016/j.exger.2019.110722.Šoltys K., Lendvorský L., Hric I. et al. Strenuous Physical Training, Physical Fitness, Body Composition and Bacteroides to Prevotella Ratio in the Gut of Elderly Athletes. Front Physiol. 2021;12:670989. doi: 10.3389/fphys.2021.670989.Šoltys K., Lendvorský L., Hric I. et al. Strenuous Physical Training, Physical Fitness, Body Composition and Bacteroides to Prevotella Ratio in the Gut of Elderly Athletes. Front Physiol. 2021;12:670989. doi: 10.3389/fphys.2021.670989.Davis J. A., Collier F., Mohebbi M. et al. The associations of butyrate-producing bacteria of the gut microbiome with diet quality and muscle health. Gut Microbiome. 2021;2: e2. doi: 10.1017/gmb.2021.2Davis J. A., Collier F., Mohebbi M. et al. The associations of butyrate-producing bacteria of the gut microbiome with diet quality and muscle health. Gut Microbiome. 2021;2: e2. doi: 10.1017/gmb.2021.2Zhao J., Huang Y., Yu X. A Narrative Review of Gut-Muscle Axis and Sarcopenia: The Potential Role of Gut Microbiota.Int J Gen Med. 2021;14:1263-1273. doi: 10.2147/IJGM.S301141.Zhao J., Huang Y., Yu X. A Narrative Review of Gut-Muscle Axis and Sarcopenia: The Potential Role of Gut Microbiota.Int J Gen Med. 2021;14:1263-1273. doi: 10.2147/IJGM.S301141.Fan P., Li L., Rezaei A. et al. Metabolites of Dietary Protein and Peptides by Intestinal Microbes and their Impacts on Gut. Curr Protein Pept Sci. 2015;16(7):646-654. doi: 10.2174/1389203716666150630133657.Fan P., Li L., Rezaei A. et al. Metabolites of Dietary Protein and Peptides by Intestinal Microbes and their Impacts on Gut. Curr Protein Pept Sci. 2015;16(7):646-654. doi: 10.2174/1389203716666150630133657.Windey K., De Preter V., Verbeke K. Relevance of protein fermentation to gut health. Mol Nutr Food Res. 2012;56(1):184-196. doi: 10.1002/mnfr.201100542.Windey K., De Preter V., Verbeke K. Relevance of protein fermentation to gut health. Mol Nutr Food Res. 2012;56(1):184-196. doi: 10.1002/mnfr.201100542.Smith E. A., Macfarlane G. T. Enumeration of human colonic bacteria producing phenolic and indolic compounds: effects of pH, carbohydrate availability and retention time on dissimilatory aromatic amino acid metabolism. J Appl Bacteriol. 1996;81(3):288-302. doi: 10.1111/j.1365-2672.1996.tb04331.x.Smith E. A., Macfarlane G. T. Enumeration of human colonic bacteria producing phenolic and indolic compounds: effects of pH, carbohydrate availability and retention time on dissimilatory aromatic amino acid metabolism. J Appl Bacteriol. 1996;81(3):288-302. doi: 10.1111/j.1365-2672.1996.tb04331.x.Jakobsson H. E., Rodríguez-Piñeiro A. M., Schütte A. et al. The composition of the gut microbiota shapes the colon mucus barrier. EMBO Rep. 2015;16(2):164-177. doi: 10.15252/embr.201439263.Jakobsson H. E., Rodríguez-Piñeiro A. M., Schütte A. et al. The composition of the gut microbiota shapes the colon mucus barrier. EMBO Rep. 2015;16(2):164-177. doi: 10.15252/embr.201439263.Pasini E., Corsetti G., Aquilani R. et al. Protein-Amino Acid Metabolism Disarrangements: The Hidden Enemy of Chronic Age-Related Conditions. Nutrients. 2018;10(4):391. doi: 10.3390/nu10040391.Pasini E., Corsetti G., Aquilani R. et al. Protein-Amino Acid Metabolism Disarrangements: The Hidden Enemy of Chronic Age-Related Conditions. Nutrients. 2018;10(4):391. doi: 10.3390/nu10040391.Anker S. D., Chua T. P., Ponikowski P. et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation. 1997;96(2):526-534. doi: 10.1161/01.cir.96.2.526.Anker S. D., Chua T. P., Ponikowski P. et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation. 1997;96(2):526-534. doi: 10.1161/01.cir.96.2.526.Katsanos C. S., Kobayashi H., Sheffield-Moore M. et al. Aging is associated with diminished accretion of muscle proteins after the ingestion of a small bolus of essential amino acids. Am J Clin Nutr. 2005;82(5):1065-1073. doi: 10.1093/ajcn/82.5.1065.Katsanos C. S., Kobayashi H., Sheffield-Moore M. et al. Aging is associated with diminished accretion of muscle proteins after the ingestion of a small bolus of essential amino acids. Am J Clin Nutr. 2005;82(5):1065-1073. doi: 10.1093/ajcn/82.5.1065.Martone A. M., Marzetti E., Calvani R. et al. Exercise and Protein Intake: A Synergistic Approach against Sarcopenia. Biomed Res Int. 2017;2017:2672435. doi: 10.1155/2017/2672435.Martone A. M., Marzetti E., Calvani R. et al. Exercise and Protein Intake: A Synergistic Approach against Sarcopenia. Biomed Res Int. 2017;2017:2672435. doi: 10.1155/2017/2672435.Bauer J., Biolo G., Cederholm T. et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc. 2013;14(8):542-559. doi: 10.1016/j.jamda.2013.05.021.Bauer J., Biolo G., Cederholm T. et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc. 2013;14(8):542-559. doi: 10.1016/j.jamda.2013.05.021.Nay K., Jollet M., Goustard B. et al. Gut bacteria are critical for optimal muscle function: a potential link with glucose homeostasis. Am J Physiol Endocrinol Metab. 2019;317(1): E158-E171. doi: 10.1152/ajpendo.00521.2018.Nay K., Jollet M., Goustard B. et al. Gut bacteria are critical for optimal muscle function: a potential link with glucose homeostasis. Am J Physiol Endocrinol Metab. 2019;317(1): E158-E171. doi: 10.1152/ajpendo.00521.2018.Strasser B., Wolters M., Weyh C. et al. The Effects of Lifestyle and Diet on Gut Microbiota Composition, Inflammation and Muscle Performance in Our Aging Society. Nutrients. 2021;13(6):2045. doi: 10.3390/nu13062045.Strasser B., Wolters M., Weyh C. et al. The Effects of Lifestyle and Diet on Gut Microbiota Composition, Inflammation and Muscle Performance in Our Aging Society. Nutrients. 2021;13(6):2045. doi: 10.3390/nu13062045.Picca A., Calvani R., Cesari M. et al. Biomarkers of Physical Frailty and Sarcopenia: Coming up to the Place? Int J Mol Sci. 2020;21(16):5635. doi: 10.3390/ijms21165635.Picca A., Calvani R., Cesari M. et al. Biomarkers of Physical Frailty and Sarcopenia: Coming up to the Place? Int J Mol Sci. 2020;21(16):5635. doi: 10.3390/ijms21165635.Chu H., Duan Y., Yang L., Schnabl B. Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease. Gut. 2019;68(2):359-370. doi: 10.1136/gutjnl-2018-316307.Chu H., Duan Y., Yang L., Schnabl B. Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease. Gut. 2019;68(2):359-370. doi: 10.1136/gutjnl-2018-316307.van Krimpen S. J., Jansen F. A.C., Ottenheim V. L. et al. The Effects of Pro-, Pre-, and Synbiotics on Muscle Wasting, a Systematic Review-Gut Permeability as Potential Treatment Target. Nutrients. 2021;13(4):1115. doi: 10.3390/nu13041115.van Krimpen S. J., Jansen F. A.C., Ottenheim V. L. et al. The Effects of Pro-, Pre-, and Synbiotics on Muscle Wasting, a Systematic Review-Gut Permeability as Potential Treatment Target. Nutrients. 2021;13(4):1115. doi: 10.3390/nu13041115.Cederbaum A. I. Alcohol metabolism. Clin Liver Dis. 2012;16(4):667-685. doi: 10.1016/j.cld.2012.08.002.Cederbaum A. I. Alcohol metabolism. Clin Liver Dis. 2012;16(4):667-685. doi: 10.1016/j.cld.2012.08.002.Osna N. A., Donohue T. M. Jr., Kharbanda K. K. Alcoholic Liver Disease: Pathogenesis and Current Management. Alcohol Res. 2017;38(2):147-161.Osna N. A., Donohue T. M. Jr., Kharbanda K. K. Alcoholic Liver Disease: Pathogenesis and Current Management. Alcohol Res. 2017;38(2):147-161.Holeček M. Muscle Amino Acid and Adenine Nucleotide Metabolism during Exercise and in Liver Cirrhosis: Speculations on How to Reduce the Harmful Effects of Ammonia. Metabolites. 2022;12(10):971. doi: 10.3390/metabo12100971.Holeček M. Muscle Amino Acid and Adenine Nucleotide Metabolism during Exercise and in Liver Cirrhosis: Speculations on How to Reduce the Harmful Effects of Ammonia. Metabolites. 2022;12(10):971. doi: 10.3390/metabo12100971.Walker V. Ammonia metabolism and hyperammonemic disorders. Adv Clin Chem. 2014;67:73-150. doi: 10.1016/bs.acc.2014.09.002.Walker V. Ammonia metabolism and hyperammonemic disorders. Adv Clin Chem. 2014;67:73-150. doi: 10.1016/bs.acc.2014.09.002.McCullough A. J., Mullen K. D., Kalhan S. C. Body cell mass and leucine metabolism in cirrhosis. Gastroenterology. 1992;102(4 Pt 1):1325-1333. doi: 10.1016/0016-5085(92)90772-Q.McCullough A. J., Mullen K. D., Kalhan S. C. Body cell mass and leucine metabolism in cirrhosis. Gastroenterology. 1992;102(4 Pt 1):1325-1333. doi: 10.1016/0016-5085(92)90772-Q.Dasarathy S., Merli M. Sarcopenia from mechanism to diagnosis and treatment in liver disease. J Hepatol. 2016;65(6):1232-1244. doi: 10.1016/j.jhep.2016.07.040.Dasarathy S., Merli M. Sarcopenia from mechanism to diagnosis and treatment in liver disease. J Hepatol. 2016;65(6):1232-1244. doi: 10.1016/j.jhep.2016.07.040.European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J Hepatol. 2019;70(1):172-193. doi: 10.1016/j.jhep.2018.06.024.European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J Hepatol. 2019;70(1):172-193. doi: 10.1016/j.jhep.2018.06.024.Peng S., Plank L. D., McCall J. L. et al. Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: a comprehensive study. Am J Clin Nutr. 2007;85(5):1257-1266. doi: 10.1093/ajcn/85.5.1257.Peng S., Plank L. D., McCall J. L. et al. Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: a comprehensive study. Am J Clin Nutr. 2007;85(5):1257-1266. doi: 10.1093/ajcn/85.5.1257.Schnabl B., Brenner D. A.Interactions between the intestinal microbiome and liver diseases. Gastroenterology. 2014;146(6):1513-1524. doi: 10.1053/j.gastro.2014.01.020.Schnabl B., Brenner D. A.Interactions between the intestinal microbiome and liver diseases. Gastroenterology. 2014;146(6):1513-1524. doi: 10.1053/j.gastro.2014.01.020.Blomstrand E., Hassmén P., Ekblom B., Newsholme E. A. Administration of branched-chain amino acids during sustained exercise - effects on performance and on plasma concentration of some amino acids. Eur J Appl Physiol Occup Physiol. 1991;63(2):83-88. doi: 10.1007/BF00235174.Blomstrand E., Hassmén P., Ekblom B., Newsholme E. A. Administration of branched-chain amino acids during sustained exercise - effects on performance and on plasma concentration of some amino acids. Eur J Appl Physiol Occup Physiol. 1991;63(2):83-88. doi: 10.1007/BF00235174.Holeček M., Vodeničarovová M. Effects of branched-chain amino acids on muscles under hyperammonemic conditions. J Physiol Biochem. 2018;74(4):523-530. doi: 10.1007/s13105-018-0646-9.Holeček M., Vodeničarovová M. Effects of branched-chain amino acids on muscles under hyperammonemic conditions. J Physiol Biochem. 2018;74(4):523-530. doi: 10.1007/s13105-018-0646-9.

The authors declare that there are no conflicts of interest present.